TrialThe Lancet. Oncology2020

Adjuvant denosumab in early breast cancer (D-CARE): an international, multicentre, randomised, controlled, phase 3 trial.

Robert Coleman et al.PubMed ↗Publisher ↗

No numbers read from the abstract.